Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04565925 · ClinicalTrials.gov registry record · Phase 2
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
A Phase 2 study of Spinal Cord Injuries and Urinary Incontinence, sponsored by The University of Texas Medical Branch, Galveston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT04565925: Recruiting Phase 2 study of Spinal Cord Injuries and Urinary Incontinence, sponsored by The University of Texas Medical Branch, Galveston.
NCT04565925 is a Phase 2 study of Spinal Cord Injuries and Urinary Incontinence that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 24 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04565925, a Phase 2 study of Spinal Cord Injuries and Urinary Incontinence, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.
Primary Outcome
Bladder leakage will be measured by bladder diary, which will be kept for five- 24 hours periods at baseline. Subjects will be asked to record the number of leaks each day. Data will be calculated by summing total number of leaks over the 5 day recording period and dividing the sum by 5, resulting in average leaks per day.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Sildenafil Citrate
Study Locations (2)
Texas
- Texas A&M University - College Station
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-07-07 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 2 |
What NCT04565925 shows while recruiting
NCT04565925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04565925 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04565925 about?
NCT04565925 is a clinical study titled "Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries". The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.
What is the current status of trial NCT04565925?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2021-07-07. Estimated completion is 2026-12-01.
What conditions does trial NCT04565925 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Urinary Incontinence.
What interventions are being tested in trial NCT04565925?
The interventions under investigation include: Placebo (DRUG), Sildenafil Citrate (DRUG).
Who is sponsoring clinical trial NCT04565925?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04565925 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04565925's enrollment target sits among peer trials
24 114th of 202 higher than 82 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Epidural Stimulation and Resistance Training After SCI
RECRUITING · Phase 2
-
Intravesical LGG VS Saline Bladder Wash RCT
RECRUITING · Phase 2
-
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Effects of 5HTP on the Injured Human Spinal Cord
RECRUITING · Phase 2
-
Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy